GO | Name |
GO:0001758 | retinal dehydrogenase activity |
GO:0004032 | alditol:NADP+ 1-oxidoreductase activity |
GO:0004033 | aldo-keto reductase (NADP) activity |
GO:0004303 | estradiol 17-beta-dehydrogenase activity |
GO:0005634 | nucleus |
GO:0005737 | cytoplasm |
GO:0005829 | cytosol |
GO:0006693 | prostaglandin metabolic process |
GO:0006694 | steroid biosynthetic process |
GO:0008202 | steroid metabolic process |
GO:0016229 | steroid dehydrogenase activity |
GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor |
GO:0032052 | bile acid binding |
GO:0042448 | progesterone metabolic process |
GO:0042493 | response to drug |
GO:0043627 | response to estrogen |
GO:0044597 | daunorubicin metabolic process |
GO:0044598 | doxorubicin metabolic process |
GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity |
GO:0047023 | androsterone dehydrogenase activity |
GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity |
GO:0047086 | ketosteroid monooxygenase activity |
GO:0047743 | chlordecone reductase activity |
GO:0047834 | D-threo-aldose 1-dehydrogenase activity |
GO:0048025 | negative regulation of mRNA splicing, via spliceosome |
GO:0071395 | cellular response to jasmonic acid stimulus |